Corticosteroid: Clinical Trials

45 trials of Corticosteroid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

19 completed, 9 unknown, 6 terminated, 4 recruiting. 45 Phase 2, 8 Phase 1, 5 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 245Completed 19, Unknown 9, Terminated 6, Recruiting 4, Withdrawn 4, Active not recruiting 1, Not yet recruiting 1, Suspended 1
Phase 18Completed 3, Unknown 2, Not yet recruiting 1, Suspended 1, Withdrawn 1
Phase 35Completed 3, Unknown 1, Withdrawn 1

Follow Corticosteroid: new trials by email Literature Review of Corticosteroid trials Research Report on Corticosteroid

Trials (filtered) newest first · largest first

All 45 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Clinical Trial of MK-2750 in Participants With Advanced Solid Tumors (MK-2750-002)
MK-2750, 5-HT3 serotonin receptor antagonist, NK-1 receptor antagonist - Advanced Solid Tumors, Malignant Neoplasm
Phase 1 / Phase 2Not yet recruitingMerck Sharp & Dohme LLC3002026-11-162026-10-15
Corticosteroid Against Saline Injections for Thumb Osteoarthritis (CASITOA)
Saline Solution (NaCl 0,9%), Triamcinolone Acetonide - Trapeziometacarpal Osteoarthritis
Phase 2RecruitingUniversité du Québec à Trois-Rivières402025-11-042026-08-18
A Study of Investigational Agents in Participants With Previously Treated Stage IV Nonsquamous Non-small Cell Lung Cancer (NSCLC) (MK-3475-01H/KEYMAKER-U01)
Raludotatug Deruxtecan, Ifinatamab Deruxtecan, Docetetaxel - Carcinoma, Non-Small-Cell Lung
Phase 2Active not recruitingMerck Sharp & Dohme LLC962025-05-132026-11-06
Reducing Respiratory Symptoms of Pulmonary Irradiation in Interstitial Lung Disease
N-Acetyl cysteine, Dexamethasone Oral, N-Acetyl cysteine Placebo - Lung Cancer, Interstitial Lung Disease
Phase 2RecruitingDavid Palma982025-01-072026-08-26
Early Adalimumab Induction for Immune Checkpoint Inhibitor Associated Inflammatory Arthritis
Adalimumab, Prednisone - Inflammatory Arthritis, Immune-related Adverse Event
Phase 2RecruitingTom Appleton302024-04-152026-03-03
Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases
Azeliragon, Stereotactic radiosurgery, Corticosteroid - Cancer, Metastasis
Phase 1 / Phase 2SuspendedBaptist Health South Florida462023-11-172026-06-16
Treating Exacerbations of Asthma With Oral Montelukast in Children
Montelukast Oral Granules, Albuterol, Corticosteroid - Status Asthmaticus
Phase 2CompletedVanderbilt University Medical Center902023-10-202026-07-02
Itacitinib for the Treatment Steroid Refractory Immune Related Adverse Events Arising From Immune Checkpoint Inhibitors
Itacitinib, Corticosteroid, Endoscopic Procedure - Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm
Phase 2WithdrawnDouglas Johnson2023-03-032026-04-27
Efficacy of CTM for Tennis ELbow
CTM, Celestone - Tennis Elbow, Lateral Epicondylitis \(Tennis Elbow\)
Phase 2UnknownIndiana Hand to Shoulder Center542023-01-262024-03-27
Mesenchymal Stem Cell Therapy for Knee Osteoarthritis
Bone Marrow Derived MSCs, Corticosteroid, Bone Marrow Aspirate - Osteoarthritis, Knee
Phase 1 / Phase 2UnknownNext Generation Regenerative Medicine LLC1202022-08-012022-03-21
Selective CD28 Blockade in Renal Transplant Recipients
Lulizumab, Tacrolimus, Thymoglobulin® - Kidney Transplantation, Renal Transplant Recipients
Phase 2WithdrawnNational Institute of Allergy and Infectious Diseases (NIAID)2022-01-102023-03-22
Elotuzumab in Immunoglobulin G4-Related Disease (IgG4-RD)
elotuzumab, placebo for elotuzumab, methylprednisolone - IgG4 Related Disease, IgG4-RD
Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)82021-10-132026-02-05
MTX and Steroid for III-IV aGVHD Treatment
Methotrexate - Acute Graft Versus Host Disease
Phase 2UnknownPeking University People's Hospital302021-04-212022-04-20
MTX and Steroid for aGVHD Treatment
Methotrexate - Acute GVH Disease
Phase 2UnknownPeking University People's Hospital302020-12-232021-09-16
Belatacept in De Novo Heart Transplantation
Belatacept, Tacrolimus, Mycophenolate Mofetil - Heart Transplantation
Phase 2RecruitingNYU Langone Health122020-08-062025-12-04
Intraarticular Leukocyte-rich and Leukocyte-poor PRP for Osteoarthritis of the Knee
Leukocyte-rich platelet-rich plasma, Leukocyte-poor platelet-rich plasma, Corticosteroid - Osteo Arthritis Knee
Phase 2 / Phase 3CompletedQueen Savang Vadhana Memorial Hospital, Thailand932020-08-032023-02-21
Post-operative Corticosteroid Treatment After Mitral Valve Surgery
Hydrocortisone, Placebos - Atrial Fibrillation
Phase 2 / Phase 3WithdrawnKuopio University Hospital2020-01-012022-04-07
First Line Therapy for High Risk Acute GVHD
Ruxolitinib, Corticosteroid - aGVHD, Stem Cell Transplant Complications
Phase 2CompletedChinese PLA General Hospital1982019-08-252023-11-29
Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury
Lipogems, Dexamethasone - Spinal Cord Injuries, Tendinopathy
Phase 2UnknownKessler Foundation242019-06-142022-10-14
Safety and Tolerability of ISX (Isoxsuprine HCL) in MS Relapses
Isoxsuprine Hydrochloride, Placebo, Corticosteroid - Multiple Sclerosis
Phase 1 / Phase 2CompletedUniversity of New Mexico22019-02-152024-02-06

Showing 20 of 45. Sign in to see all of them.

Conditions studied

Neoplasms (3)  ·  Prostatic Neoplasms (3)  ·  Carcinoma, Non-Small-Cell Lung (2)  ·  Lymphoma (2)  ·  Multiple Myeloma (2)  ·  Neoplasm Metastasis (2)  ·  Osteoarthritis (2)  ·  Osteoarthritis, Knee (2)  ·  Rejection, Psychology (2)  ·  Tennis Elbow (2)  ·  Arthritis (1)  ·  Asthma (1)  ·  Atrial Fibrillation (1)  ·  Autoimmune Diseases (1)  ·  Brain Neoplasms (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (4)  ·  H. Lee Moffitt Cancer Center and Research Institute (3)  ·  Celgene (2)  ·  Merck Sharp & Dohme LLC (2)  ·  NYU Langone Health (2)  ·  Peking University People's Hospital (2)  ·  Amgen (1)  ·  Baptist Health South Florida (1)  ·  Chinese PLA General Hospital (1)  ·  Clearside Biomedical, Inc. (1)  ·  David Palma (1)  ·  Dokuz Eylul University (1)  ·  Douglas Johnson (1)  ·  Erasmus Medical Center (1)  ·  Genzyme, a Sanofi Company (1)

Countries

United States (23)  ·  Canada (6)  ·  China (5)  ·  Germany (5)  ·  Italy (3)  ·  Spain (3)  ·  Denmark (2)  ·  Finland (2)  ·  Netherlands (2)  ·  Turkey (Türkiye) (2)  ·  United Kingdom (2)  ·  Austria (1)  ·  Brazil (1)  ·  Chile (1)  ·  Estonia (1)

Top investigators

Anant Joshi, Dr. (1)  ·  Andrew B. Adams, MD, PhD (1)  ·  Angeliki Kazeros, MD (1)  ·  Anthony D. Ho, Ph.D., Prof. (1)  ·  Aryeh Fischer, MD (1)  ·  Celeste Bello, M.D. (1)  ·  Christian P. Larsen, MD, DPhil (1)  ·  Christoph Czarnetzki, MD (1)  ·  Colleen Fitzgerald, MD (1)  ·  Corey C Ford, M.D., Ph.D. (1)  ·  Daihong Liu (1)  ·  David B. Badesch, M.D. (1)

Results publications

PMID 12081113, PMID 1991946, PMID 23406536, PMID 25035839, PMID 25091040, PMID 25161985, PMID 25320358, PMID 25925602, PMID 25963758, PMID 26432430, PMID 27683182, PMID 27980877, PMID 28012636, PMID 28386761, PMID 28469486, PMID 28639856, PMID 28963118, PMID 29885994, PMID 30454753, PMID 30623236, PMID 30632533, PMID 31056949, PMID 32134978, PMID 32960980, PMID 33651671, PMID 33856964, PMID 34107229, PMID 34107236, PMID 34799501, PMID 34826301, PMID 35103547, PMID 35123640, PMID 35503708, PMID 35668528, PMID 38301682, PMID 38829437, PMID 39438467, PMID 42191192

NIH funding

2015 (2), 2016 (1), 2025 (1), U01AI138909 (1), UM1AI144298 (1)